ロード中...
The Mutant KRAS Gene Up-regulates BCL-XL Protein via STAT3 to Confer Apoptosis Resistance That Is Reversed by BIM Protein Induction and BCL-XL Antagonism
In colorectal cancers with oncogenic GTPase Kras (KRAS) mutations, inhibition of downstream MEK/ERK signaling has shown limited efficacy, in part because of failure to induce a robust apoptotic response. We studied the mechanism of apoptosis resistance in mutant KRAS cells and sought to enhance the...
保存先:
| 出版年: | J Biol Chem |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Biochemistry and Molecular Biology
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4583008/ https://ncbi.nlm.nih.gov/pubmed/26245900 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M115.657833 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|